DMACDiaMedica Therapeutics Inc.

Healthcare
$8.01+17% 1Y

The financials

DiaMedica Therapeutics Inc. by the numbers

The next results filing is expected around Nov 11, 2026, the same week as a year ago.

DiaMedica Therapeutics Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$10M−$8.0Mn/a
Net income−$10M−$7.7Mn/a

Biotechnology

Ranks #120 of 196 by RyuScore

Compare peers
EDIT+3.3%
Editas Medicine, Inc.
TECX-0.20%
Tectonic Therapeutic, Inc.
OVID-0.64%
Ovid Therapeutics Inc.
NGNE+2.3%
Neurogene Inc.
RGNX+6.5%
REGENXBIO Inc.
RZLT+5.6%
Rezolute, Inc.